Home
About Us
Research Projects
Research Staff
Career Opportunities
Contact Us
Employee Advisories
DCCT Bibliography
DIABETES CONTROL AND COMPLICATIONS TRIAL BIBLIOGRAPHY
With links to journal article abstracts where available

57. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia, 41:416-423, 1998. Journal Article

56. The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual Beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial: A randomized, controlled trial. Annals of Internal Medicine, 128:517-523, 1998. Journal Article

55. The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Archives of Ophthalmology, 116:874-886, 1998.

54. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA and Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: Results from the DCCT. Journal of the American Medical Association, 280:140-146, 1998.

53. The Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes, 46:1829-1839, 1997.

52. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trail. Diabetes, 46:271-286, 1997.

51. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes, 45:1289-1298, 1996.

50. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. Journal of the American Medical Association, 276:1409-1415, 1996.

49. The Diabetes Control and Complications Trial Research Group. Pregnancy outcomes in the Diabetes Control and Complications Trial. American Journal of Obstetrics and Gynecology,, 174:1343-1353, 1996.

48. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality-of-life outcomes in the Diabetes Control and Complications Trial. Diabetes Care, 19:195-203, 1996.

47. The Diabetes Control and Complications Trial Research Group. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Annals of Internal Medicine, 124:379-388, 1996.

46. Leiter L, and the Diabetes Control and Complications Trial Research Group. Use of bioelectrical impedance analysis measurements in patients with diabetes. American Journal of Clinical Nutrition, 64 (suppl.): 515S-518S, 1996.

45. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Annals of Neurology, 38:869-880, 1995.

44. The Diabetes Control and Complications Trial Research Group. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care, 18:1415-1427, 1995.

43. The Diabetes Control and Complications Trial Research Group. Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care, 18:1468-1478, 1995.

42. Purnell JQ, Marcovina SM, Hokanson JE, Kennedy H, Cleary PA, Steffes MW, and Brunzell JD. Levels of lipoprotein (a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial. Diabetes, 44:1218-1226, 1995.

41. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes, 44:968-983, 1995.

40. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. The American Journal of Cardiology, 75:894-903, 1995.

39. The Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney International, 47:1703-1720, 1995.

38. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Annals of Internal Medicine, 122:561-568, 1995.

37. The Diabetes Control and Complications Trial Research Group; and Klein R, Moss S. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Archives of Internal Medicine, 155:745-754, 1995.

36. The Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology, 102:647-661, 1995.

35. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial. Archives of Ophthalmology, 113:36-51, 1995.

34. Diabetes Control and Complications Trial Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care, 18:361-376, 1995.

33. The Diabetes Control and Complications Trial Research Group. Psychological aspects of the DCCT. In The Technology of Diabetes Care: Converging Medical and Psychosocial Perspectives, 122-139, 1994.

32. Leiter LA, Lukaski HC, Kenny DJ, Barnie A, Camelon K, Ferguson RS, MacLean S, Simkins S, Zinman B and Cleary PA for the DCCT Research Group. The use of Bioelectrical Impedance Analysis (BIA) to estimate body composition in the Diabetes Control and Complications Trial (DCCT). International Journal of Obesity, 18:829-835, 1994.

31. Schmidt LE, Cox MS, Buzzard IM, and Cleary PA, for the DCCT Research Group. Reproducibility of a comprehensive diet history in the Diabetes Control and Complications Trial. Journal of the American Dietetic Association, 94:1392-1397, 1994.

30. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. The Journal of Pediatrics, 125:177-188, 1994.

29. The DCCT Research Group. A screening algorithm to identify clinically significant changes in neuropsychological functions in the Diabetes Control and Complications Trial. Journal of Clinical and Experimental Neuropsychology, 16:303-316, 1994.

28. Siebert C and Clark CM. Operational and policy considerations of data monitoring in clinical trials: the Diabetes Control and Complications Trial experience. Controlled Clinical Trials , 14(1): 30-44, 1993.

27. The DCCT Research Group. The impact of the trial coordinator in the Diabetes Control and Complications Trial. Diabetes Educator, 19:509-512, 1993.

26. Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA, Molitch ME, Mitch WE, Siebert C, Hall PM, and Steffes MW, for the Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. Glomerular filtration rate measurements in clinical trials. Journal of the American Society of Nephrology, 4:1159-1171, 1993.

25. The Diabetes Control and Complications Trial Research Group. Nutrition interventions for intensive therapy in the Diabetes Control and Complications Trial. The Journal of the American Dietetic Association, 93:768-772, 1993.

24. The DCCT Research Group. Expanded role of the dietitian in the Diabetes Control and Complications Trial: Implications for clinical practice. The Journal of the American Dietetic Association, 93:758-767, 1993.

23. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine, 329:977-986, 1993.

22. The Diabetes Control and Complications Trial Research Group. Baseline analysis of renal function in the Diabetes Control and Complications Trial. Kidney International, 43:668-674, 1993.

21. The DCCT Research Group. Lipid and lipoprotein levels in patients with IDDM: Diabetes Control and Complications Trial Experience. Diabetes Care, 15:886-894, 1992.

20. Ryan CM, Adams KA, Heaton RK, Grant I, Jacobson AM and the DCCT Research Group. Neurobehavioral assessment of medical patients in clinical trials: The DCCT Experience. In Handbook of Clinical Trials; The Neurobehavioral Approach. Erich Mohr and Pim Brouwers, Eds. Amsterdam/Lisse: Swets and Zeitlinger, 215-241, 1991.

19. The DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. The American Journal of Medicine, 90:450-59, 1991.

18. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT): Update. Diabetes Care, 13:427-433, 1990.

17. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT): The trial coordinator perspective. Diabetes Educator, 15:236-241, 1989.

16. The DCCT Research Group. The DCCT: Will it answer the questions? Diabetes 1988, R. Larkins, P. Zimmet, D. Chisolm, editors, Elsevier Science Publishers B.V. (Biomedical Division), 847-855, 1989.

15. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT): Results of the feasibility study and design of the full-scale clinical trial. Pediatric and Adolescent Endocrinology, Laron Z, Karp M (eds) Basel, Karger, 18:15-21, 1989.

14. The DCCT Research Group. Implementation of a multicomponent process to obtain informed consent in the Diabetes Control and Complications Trial. Controlled Clinical Trials, 10:83-96, 1989.

13. The DCCT Research Group. Update. Diabetes Spectrum, 1:187-190, 1988.

12. The DCCT Research Group. Reliability and validity of diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care, 11:725-732, 1988.

11. The DCCT Research Group. Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care, 11:567-573, 1988.

10. Schumer M, Burton G, Burton C, Crum D, Pfeifer MA, the DCCT Study Group. Diabetic autonomic neuropathy-Part I: Autonomic nervous system data analysis by a computerized central unit in a multicenter trial. The American Journal of Medicine, 85 (suppl. 5A):137-143, 1988.

9. Hanssen KF, The DCCT Research Group, and Brunetti P. Is there a need for a continuation of the DCCT in 1988? Diabetes Nutrition and Metabolism, 1:151-159, 1988.

8. The DCCT Research Group. Factors in development of diabetic neuropathy: Baseline analysis of neuropathy in feasibility phase of the Diabetes Control and Complications Trial (DCCT). Diabetes, 37:476-481, 1988.

7. The DCCT Research Group. Are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes mellitus justified? The Diabetes Control and Complications Trial. The New England Journal of Medicine, 318:246-250, 1988.

6. The Diabetes Control and Complications Trial Research Group. Color photography vs. fluorescein angiography in the detection of diabetic retinopathy in the Diabetes Control and Complications Trial. Archives of Ophthalmology, 105:1344-1351, 1987.

5. The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care, 10:1-19, 1987.

4. The DCCT Research Group. Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: A multicenter study. Clinical Chemistry, 33:2267-2271, 1987.

3. The DCCT Research Group. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual Beta-cell function: Observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). Journal of Clinical Endocrinology and Metabolism, 65:30-36, 1987.

2. The DCCT Research Group. Treatment regimen design in the Diabetes Control and Complications Trial (DCCT). Transplantation Proceedings, XVIII(6):1678-1680, 1986.

1. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT): Design and methodologic considerations for the feasibility phase. Diabetes, 35:530-545, 1986.